chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a consumer concerning her 24 month old granddaughter. The caller reported that she had shingles about a month and a half ago and she went to visit her grandchildren. The youngest got chickenpox from her and she was under one year of age and had not been vaccinated yet. However, the older child on approximately 23-JAN-2009 got chickenpox from the younger child and she was vaccinated with a dose of VARIVAX (lot not provided) a couple months before. The chickenpox was not as severe on the older child as it was on the younger one. No further information is available.
I did not have an adverse reaction to the vaccine but tested positive for COVID-19 on 07/01/2022 .  I took a home test for COVID-19 of 06/29/2022. I talked to my primary care physician via telehealth and she prescribed Paxlovid. As of today, I am feeling better. I have not retested to see if I am positive.
Within 24 hours of administration of vaccine pt stated "her throat started to swell shut" pt saw Nurse Practicioner who gave Benadryl and 3 day course of Steroids
This spontaneous report as received from a physician refers to a patient of unknown age and gender with leukemia. On an unknown date, the patient was vaccinated with the second dose of PNEUMOVAX 23 (route, lot #, expiration date were not provided). On an unknown date, the physician wanted to give PREVNAR 13, a second dose of second dose of PNEUMOVAX 23 was given. The physician inquired how long to wait until get the PREVNAR 13. At the time of the report, the patient's status was unknown. Additional information has been requested.
I was severe fatigue, diarrhea, nausea and vomiting of about a week after the shot. I contacted my doctor. He gave me a nausea medicine and then I felt better.
Was given a shot of PPV Pneumococcal Polysaccharide.  Reaction: Runny nose, severe Arm Pain, fever 99.2 next day from shot, temp 102 second day from shot, muscle ache, head ache, not thinking clearly.  Unable to go into work on second day from dose.
After 11 hours of getting the vaccine I believe I experienced a sleep seizure. I woke up abruptly, shaking uncontrollably with absolutely no control over myself. Since then I've only experienced the normal side effects, muscle fatigue, headaches etc.
Mother called on 12/6/01 stating 5 mins. post child received IPV, she complained of 'Hand feeling funny". This was not reported to nurses. 30 mins. later , legs felt weak. approximately three hours, was pale and dizzy. Seen in ER. BO ok per mom. Prescribed Benadryl took 1 dose last night child refused it this am, went out with friends for 1/2 hour and came back not feeling well. Weak. given Benadryl. No respiratory difficulty or hives noted by mom.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date in 2014, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), at a pharmacy, as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 05-JUL-2016, the patient was treated by a physician for a blistering vesicular outbreak, which was diagnosed as herpes zoster. The patient was prescribed acyclovir for management of his painful symptoms and chronic pain. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
on December 21, 2021 at a routine follow-up patient reported that he had  developed shortness of breath with exertion  at some point after getting second dose of COVID-19 vaccine.  patient had no previous history of lung disease occluding asthma.  History of using oral tobacco but never smoking.
Overnight b/w 5/26/18 and 5/27/18 pt. experienced chills, aches, and a fever of 101. Didn't experience w/1st dose.
Onset of tachycardia and tightness in the chest after influenza injection on 09/28/2011 lasting to 9/29/2011 around 8:00 a.m. when public health nurse referred her to ER.  Around 11:50 AM patient was discharged with diagnosis of reaction to influenza injection.
This spontaneous report was received from a registered nurse. It was reported that in 2011, "over the last year", 3 to 4 patients developed redness and swelling at injection site after receiving PNEUMOVAX 23. Lot# were unspecified. All patients received an influenza virus vaccine (unspecified) at the same time that PNEUMOVAX 23 was administered. No exact date reported. The outcome of patients were unknown. Additional information has been requested.
On day 6 (4/12) I experience the following: Coughing, Aches all over, breathing issues and chest pain, hot flashes (NO fever), light headed, foggy head/concentration issues, fatigue, diarrhea, upset stomach/cramps, headache On day 11 (4/17) I experience EXTREME fatigue, headache and foggy head. Slept for over 12 consecutive hours. Aches persisted since day 1 (cleared up on day 12).  Cough ing and breathing issues and chest pain when coughing have persisted since day 3 and have not cleared up.
Onset of:    Moderate to severe chills;    moderate to severe malaise;   mild palpitations;    one day of not being able to move around house.        Got shot on a Wednesday; felt improved by following Friday.
Hypothermia - in 48 hours after vaccine and irritability/fussiness - in 24 - 48 hours after vaccine. T 95.5 rectally-required Emergency department visit & warmer applied.
injection site redness; Vaccine Administered at Inappropriate Site; This case was reported by a consumer via call center representative and described the occurrence of injection site redness in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 7th May 2019, the patient received the 2nd dose of Shingrix (subcutaneous). On 7th May 2019, less than a day after receiving Shingrix, the patient experienced injection site redness and intramuscular formulation administered by other route. On an unknown date, the outcome of the injection site redness was not recovered/not resolved and the outcome of the intramuscular formulation administered by other route was unknown.   The reporter considered the injection site redness to be related to Shingrix.  Additional details were provided as follows: The case was reported by the patient for herself. The patient received her dose of Shingrix in the fatty tissue near the under part of her right arm, which led to intramuscular formulation administered by other route. Later that day, the patient had a red circle around the injection site the size of a quarter or fifty cent piece.  In the morning of the reporting day, the circle was about the size of a large orange.  The patient asked the pharmacist about the site of the injection as her 1st dose was given in the muscle and was told by the pharmacist that this is where the CDC says it should go, that it would be better absorbed.
Patient received first dose of Pfizer COVID Vaccine and reported headache and lip tingling per observation. Given benadryl 25mg x 1.
WEIRD REACTION TO THE JANSSEN COVID-19 VACCINE; TINGLING NUMBNESS IN RIGHT ARM NON-VACCINATED ARM; SORENESS IN THE LEFT ARM; CHILLS; HEADACHES; This spontaneous report received from a patient concerned a 22 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1821281 expiry: 30-SEP-2021) dose was not reported, administered on 22-JUN-2021 12:00 for prophylactic vaccination. No concomitant medications were reported.  On 22-JUN-2021, the subject experienced weird reaction to the janssen covid-19 vaccine. On 22-JUN-2021, the subject experienced tingling numbness in right arm non-vaccinated arm. On 22-JUN-2021, the subject experienced soreness in the left arm. On 22-JUN-2021, the subject experienced chills. On 22-JUN-2021, the subject experienced headaches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from weird reaction to the janssen covid-19 vaccine, tingling numbness in right arm non-vaccinated arm, soreness in the left arm, chills, and headaches. This report was non-serious.
Reddening and striping in area of shot. Stripes ran from shoulder down toward my chest and under my arm (both torso and arm). Lasted 6 days.
not been able to eat or drink anything since then; can barely get out of bed; don't have any energy; nauseous all day and all night; feel fatigue; headache; This spontaneous case was reported by a consumer and describes the occurrence of FEEDING DISORDER (not been able to eat or drink anything since then), GAIT INABILITY (can barely get out of bed), ASTHENIA (don't have any energy), NAUSEA (nauseous all day and all night) and FATIGUE (feel fatigue) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016B21A and 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced FEEDING DISORDER (not been able to eat or drink anything since then), GAIT INABILITY (can barely get out of bed), ASTHENIA (don't have any energy), NAUSEA (nauseous all day and all night), FATIGUE (feel fatigue) and HEADACHE (headache). The patient was treated with OMEPRAZOLE at an unspecified dose and frequency and CALCIUM CARBONATE, MAGNESIUM CARBONATE (TUMS [CALCIUM CARBONATE;MAGNESIUM CARBONATE]) at an unspecified dose and frequency. At the time of the report, FEEDING DISORDER (not been able to eat or drink anything since then), GAIT INABILITY (can barely get out of bed), ASTHENIA (don't have any energy), NAUSEA (nauseous all day and all night), FATIGUE (feel fatigue) and HEADACHE (headache) outcome was unknown.            No concomitant medications were provided.
Pfizer Bivalent  vaccine was given as a first dose when Pfizer Monovalent Vaccine was ordered.  No adverse reaction occurred.  Patient was seen by the prmary care provider, medication error was discussed, reassurances given.
left arm in pain,; heavy head; felling like when he had Covid but less strong; body aches like when you have a virus; fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), PAIN IN EXTREMITY (left arm in pain,), HEAD DISCOMFORT (heavy head), MYALGIA (body aches like when you have a virus) and COVID-19 (felling like when he had Covid but less strong) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     The patient's past medical history included Blood pressure since an unknown date and COVID-19 in 2020. Concomitant products included LISINOPRIL.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced PYREXIA (fever), PAIN IN EXTREMITY (left arm in pain,), HEAD DISCOMFORT (heavy head), MYALGIA (body aches like when you have a virus) and COVID-19 (felling like when he had Covid but less strong). At the time of the report, PYREXIA (fever), PAIN IN EXTREMITY (left arm in pain,), HEAD DISCOMFORT (heavy head), MYALGIA (body aches like when you have a virus) and COVID-19 (felling like when he had Covid but less strong) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       This case was linked to US-MODERNATX, INC.-MOD-2021-041539 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-041539:husband crosslinked case
Swollen lymph nodes under right arm; This is a spontaneous report from a contactable Healthcare Professional reporting for herself. A 53-years-old, non-pregnant, female patient received the second dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine in Hospital, via an unspecified route of administration, administered in right arm on 20Feb2021 09:30 (Batch/Lot Number: EN6200) as single dose for COVID-19 immunization. The patient's medical history was not reported. Historical vaccine included the first dose of BNT162B2 Pfizer-BioNTech COVID-19 mRNA Vaccine in right arm on 25Jan2021 06:00 PM (Batch/Lot Number: EL8982) as single dose for COVID-19 immunization. The patient was not diagnosed with COVID-19 prior vaccination and was not tested for COVID post vaccination. Concomitant medication included omeprazole taken for an unspecified indication, start and stop date were not reported. The patient experienced swollen lymph nodes under right arm on 22Feb2021 06:00. No treatment was administered for the event. The event had not resolved yet at the time of the report.  No follow-up attempts are possible. No further information is expected.
Developed symptoms of tinnitus. Started feeling constant noise in my head and ringing in my ears two days after getting first shot of Covid-19 vaccine. Decided to submit report after noticing that many people in social media report the same reaction of Tinnitus and Hearing Loss/Impairment after COVID vaccination.
About two days after I received my vaccine, I was sitting out in the warm sun wearing shorts and noticed that my legs were becoming red and splotchy where exposed. I took note and thought it might be light sensitivity immediately following the vaccine, but would perhaps go away.  But it has continued to happen. Recently, I was sitting out in the warm sun wearing pants and experienced the same effect: red splotches all over my legs where they were getting warm from the sun, even though they were covered by denim. This had never happened to me previously, so I reported the occurrence to my doctor.
pt recv vax & exp urticaria, SOB, warm skin & joint aches; the experience was felt to be life threatening; No further details were provided;
Patient became pregnant after 1st dose of moderna vaccine/ 6 weeks pregnant/ found out she was pregnant when she missed her period/ Patient is pregnant; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Patient became pregnant after 1st dose of moderna vaccine/ 6 weeks pregnant/ found out she was pregnant when she missed her period/ Patient is pregnant) in a 26-year-old female patient who received mRNA-1273 (Spikevax) (batch nos. 037F21A and 045L21A) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS for an unknown indication.   On 14-Feb-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 14-Mar-2022, received second dose of mRNA-1273 (Spikevax) (Intramuscular) dosage was changed to .5 milliliter. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 05-Nov-2022. On 14-Feb-2022, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Patient became pregnant after 1st dose of moderna vaccine/ 6 weeks pregnant/ found out she was pregnant when she missed her period/ Patient is pregnant). On 14-Feb-2022, MATERNAL EXPOSURE DURING PREGNANCY (Patient became pregnant after 1st dose of moderna vaccine/ 6 weeks pregnant/ found out she was pregnant when she missed her period/ Patient is pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Mar-2022, Pregnancy test: positive (Positive) Positive.     For mRNA-1273 (Spikevax) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that the patient had no past medical history and no allergies. No treatment medications was reported. Patient's last menstrual cycle was on 26-FEB-2022.
Ear and face swelling. Headache nausea body aches chills.  I tool benadryl and ibprophin
Chills as of last night around 8 PM. This morning whole body muscle pain and chills. Unsettled stomach. Still have symptoms.
HEADACHE; FATIGUE; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced headache, and fatigue. The action taken with covid-19 vaccine was not applicable. The outcome of the headache and fatigue was not reported. This report was non-serious. This case, from the same reporter is linked to 20210624187.
This spontaneous report as received from a nurse refers to a 12 year old patient of unknown gender. Medical history and concurrent conditions were not reported. On 05-MAY-2015, the patient was vaccinated with an incorrect storaged vaccine of GARDASIL dose 1, lot # K005881, expiration date 14-JAN-2017 (dose and route were not reported). No adverse event reported. No co-suspect and concomitant therapies were reported. This is one of several reports from the same source. Additional information is not expected. All follow up requested to complete the case were received.
On 12/6/2021 Resident reported via telephone to this nurse he was having NVD, fever(100.4), SOB, HA and hypoxia; this nurse to resident cottage, assessment confirms reported S/S, dispatched ambulance to transport to ED for treatment of COVID-19 S/S S/P positive COVID-19 test from nasal swap on 3 Jan 2021. Family, MD, other staff, DON notified; called in report to Hospital.  The resident was treated in the ER and returned on 12/6/21 after about 6 hours at the hospital.  Resident returned from ED for tx of Covid-19; resident in stable condition, treated with Prednisone and dexamethasone discharged back. New orders for Prednisone PO x 4 days. F/U with PCP or return if worsening symptoms. Resident reported on 1/7/2021 he is feeling good and has no s/s of COVID-19.
INJECTION SITE PAIN; This spontaneous report received from a patient concerned a 54 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included non smoker, and alcohol user (in moderation), and other pre-existing medical conditions included the patient had no known allergies, no any drug abuse/illicit drug use. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: 1805025 expiry: UNKNOWN) dose was not reported, administered on 21-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 21-MAY-2021, the subject experienced injection site pain. The action taken with covid-19 vaccine  was not applicable. The patient had not recovered from injection site pain. This report was non-serious.
No additional AEs or PQC reported.; Caller reports patient received both VARIVAX and PROQUAD on the same day.; This spontaneous report was received from a registered nurse and refers to a 12-month-old patient of an unknown gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 04-MAY-2022, the patient was vaccinated on the same day with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, subcutaneously, 0.5 milliliter, lot #U025791 was confirmed to be valid, expiration date: 19-AUG-2023 (strength not provided), administered for prophylaxis and with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin) (PROQUAD) subcutaneous injection, subcutaneously, 0.5 milliliter, lot #U022726, expiration date: 16-JAN-2023, (strength not provided), administered for prophylaxis (Overdose).  No adverse effect was reported (No adverse event).
No adverse event; 16 patients were administered pediatric monovalent vaccines instead of bivalent boosters; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (16 patients were administered pediatric monovalent vaccines instead of bivalent boosters) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR6965B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 21-Dec-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 21-Dec-2022, the patient experienced WRONG PRODUCT ADMINISTERED (16 patients were administered pediatric monovalent vaccines instead of bivalent boosters). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (16 patients were administered pediatric monovalent vaccines instead of bivalent boosters) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (16 patients were administered pediatric monovalent vaccines instead of bivalent boosters).    This case contains information for the 16th of 16 adult patients described by the reporter.  Concomitant Medication use information was not provided by reporter.  16 patients were administered pediatric monovalent vaccines instead of bivalent boosters on 21DEC2022.   Treatment Medication use information was not provided by reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-692175 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-692175:Master case
Patient was admitted for headaches and lethargy and found to have a malfunction of his ventriculoperitoneal shunt which required surgical correction.
Joint and muscle a Aches, fever.  Headache.  General feeling unwell.
I contracted COVID-19 on 05/12/2022 with symptoms of fatigue, sneezing, productive cough, congestion, headache, myalgia, and loss of taste and smell. I was prescribed Paxlovid on 05/14/2022 via a telemedicine visit after I consulted my OB/Gyn before seeking treatment. I was ill for 7 days before my symptoms started to resolve. I have had lingering symptoms of altered taste, occasional dry cough. The weird taste could be a side effect from the Paxlovid.
After patient received the vaccine he stated he felt dizzy.  pharmacist that administered the dose watched him and asked if he felt like he needed to lay down.  said he did not feel like he needed to lay down but then stated he was starting to have a headache and left arm was feeling numb (this was the arm dose administered in).  kept monitoring him and after about 20 minutes     stated he was beginning to feel itchy.    asked him if he was having shortness of breathe to which he responded no. After a few more minutes he was still itchy and    gave him 50mg of liquid benadryl. This was at 531pm. He stated his symptoms were about the same and     checked his bp 163-99 hr 88.     continued to monitor him til about 600pm. By this time patient was able to walk around, no longer lighted headed, and numbness had resided.